Susan Younger
Psychiatry · Ridgeland, MSNPI 1598971830
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 445 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 445 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Otsuka America Pharmaceutical, Inc.$982
- Vanda Pharmaceuticals Inc.$685
- Supernus Pharmaceuticals, Inc.$355
- Tris Pharma Inc$345
- plus $3K from 20 others
What the payments were for
- Food & beverage$7,773100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 119 | $1,766 |
| Takeda Pharmaceuticals U.S.A., Inc. | 66 | $1,007 |
| Otsuka America Pharmaceutical, Inc. | 50 | $982 |
| Vanda Pharmaceuticals Inc. | 30 | $685 |
| Supernus Pharmaceuticals, Inc. | 23 | $355 |
| Tris Pharma Inc | 19 | $345 |
| Axsome Therapeutics, Inc. | 13 | $318 |
| Johnson & Johnson | 19 | $285 |
| Lundbeck LLC | 13 | $283 |
| Eisai Inc. | 13 | $229 |
| Ironshore Pharmaceuticals Inc. | 13 | $229 |
| Jazz Pharmaceuticals Inc. | 11 | $220 |
| Teva Pharmaceuticals USA, Inc. | 9 | $187 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $172 |
| E.r. Squibb & Sons, L.L.C. | 7 | $153 |
| Collegium Pharmaceutical, Inc. | 7 | $138 |
| Neurocrine Biosciences, Inc. | 7 | $138 |
| Merck | 8 | $122 |
| Shire North American Group Inc | 2 | $31 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Alfasigma USA, Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Biogen | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Bausch Health US, LLC | 1 | $13 |
How this compares
$7,773 in reported general payments places this provider in the 90th percentile of 219 psychiatry providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrileptalOxcarbazepine | 12 | $8,481 |
| Lisdexamfetamine Dimesylate | 17 | $3,857 |
| RisperdalRisperidone | 12 | $3,516 |
| Temazepam | 39 | $3,358 |
| Eszopiclone | 11 | $1,959 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 34 | $1,829 |
| Aripiprazole | 17 | $1,481 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 50 | $1,364 |
| Clonazepam | 104 | $1,245 |
| Alprazolam | 204 | $951 |
| Bupropion XlBupropion Hcl | 45 | $832 |
| Quetiapine Fumarate | 84 | $670 |
| Olanzapine | 55 | $644 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 49 | $622 |
| Doxepin Hcl | 22 | $549 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonRisperdal | $285 | $3,51612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 219 psychiatry providers in Mississippi.
Other psychiatry in Ridgeland
- Kurt BuechlerRidgeland$1.1M
- Clyde GlennRidgeland$68K
- Mark WebbRidgeland$12K
- Mark McLainRidgeland$6K
- Fawaz AbdrabboRidgeland$4K
- Avani PatelRidgeland$4K
- Maxie GordonClinton$1.3M
- Chasity TorrenceWhitfield$834K
- Jon JacksonJackson$834K
- John NortonJackson$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.